Global Health
Other · 3 quarters tracked · source-linked performance and management context.
Latest revenue
₹1,159 Cr
verified financial record
Quarters tracked
3
source records in the directory
Delivery assessment
0
Across 2 tracked commitments: 0 delivered, 2 missed.
Call date
2026-05-??
latest available source date
Signal trajectory
3 actual quartersCurrent read
0/100
Across 2 tracked commitments: 0 delivered, 2 missed.
Latest source read
What changed this quarter?
Global Health (Medanta) reported a strong Q4 FY26 with revenue of ₹1,196 crore (+25% YoY) and PAT of ₹147 crore (+14% YoY), driven by robust volume growth (IPD +23%, OPD +27%) and improving realizations (ARPOB +5% to ₹66,687). The Noida hospital ramp-up is on track, with Q4 EBITDA loss narrowing to ₹236 crore from ₹320 crore in Q3, and management expects breakeven in H2 FY27. Mature hospitals delivered steady margins of 26.7%, while developing hospitals (ex-Noida) posted 33% revenue growth and 32.4% margins. The company guided for ₹800-900 crore capex in FY27 and plans to add ~500 beds with minimal capex. Key risks include competitive intensity in Gurugram from new hospital openings and potential delays in greenfield projects.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Positive
Revenue
₹1,159 Cr
Source date
2026-05-??
Across the record
Quarter history.
History modules